Home / ASX / Bidding war erupting at API

Bidding war erupting at API

ASX

The Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) rivalry has been reignited today after Woolworths lobbed a $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API).

  • Previously, Wesfarmers had made a binding offer of $1.55 per share for the pharmacy chain, which had been recommended by the API board.

    The deal looked largely complete until Friday’s shock announcement.

    Wesfarmers and Woolworths were formerly fierce competitors in the supermarket sector before Wesfarmer’s spun-off Coles Group Ltd (ASX: COL) in 2018.

    Battle for API heats up

    Woolworths $1.75 per share cash offer via a scheme of arrangement values the Priceline Pharmacy chain owner at $872 million.

    It’s a 20 cents per share, or a 12.9%, premium to Wesfarmers $1.55 per share proposal on November 8.

    Woolworths’s bid is still subject to due diligence, which it believes will take four weeks.

    On that timeline, a binding offer would be expected by mid-January 2022.

    Woolworths deal is subject to regulatory approval, a unanimous recommendation by the API board and an independent expert concluding the bid is in shareholders’ best interests.

    Wesfarmers still holds the ace

    Woolworths’ audacious bid for API still has one critical hurdle to jump through.

    Wesfarmers bought a 19.3% stake in API, therefore it holds a substantial share of voting power against any other proposal, including Woolworths.

    Subsequently, Woolworths would need to convince the remaining 80.7% of API’s shareholders to vote in its favour.

    A scheme of arrangement requires at least 75% of shareholder votes. Therefore, the supermarket giant would need at least 92% of API’s shareholders on its side should Wesfarmers vote against the deal – no easy task.

    Woolworths has said it’s open to exploring alternative control structures, such as a takeover bid with acceptance of just 50.1%.

    Nonetheless, Wesfarmers won’t roll over easily given it’s already fended off a competing offer from Sigma Healthcare Ltd (ASX: SIG).

    The conglomerate has the right to match Woolworths’ bid, which would make for a fierce standoff.

    API response

    The API board has allowed Woolworths to undertake due diligence as it believes the offer is superior to Wesfarmers:

    “…the API Board considers that the Woolworths Proposal is reasonably capable of being valued, implemented and completed in accordance with its terms, and, if completed substantially in accordance with its terms, be more favourable to API shareholders as a whole than the Wesfarmers Scheme”

    My take

    In what is generally a quiet month for corporate Australia, Woolworths, Wesfarmers and its bankers will be working feverishly to win control for API.

    I’d expect Wesfarmers to match the bid, and then force Woolworths either to raise, or walk away.

    Either way, the battle for API looks to be heating up again.

    Information warning: The information in this article was published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate




    Print Article

    Related
    Aristocrat investors hit the jackpot with dividend up 22 per cent

    The global gaming and technology company came up trumps for shareholders in the 2024 financial year on the back of strong revenue and after-tax profit numbers.

    Jamie Nemtsas | 20th Nov 2024 | More
    ANZ follows peers down path of lower earnings but higher payout

    Higher interest payments and inflation are taking their toll on the banks, with ANZ no different to two of its peers with a lower profit number. That didn’t stop Australia’s fourth biggest mortgage lender increasing the 2024 dividend to shareholders.

    Jamie Nemtsas | 20th Nov 2024 | More
    NAB’s frothy payout ignores the flat earnings numbers

    Christmas has come early for the bank’s shareholders with the decision to slightly increase the 2024 dividend – despite a single-digit decline in the net profit and cash earnings.

    Jamie Nemtsas | 13th Nov 2024 | More
    Popular